- Lamotrigine may be associated with increased risk of cardiac arrhythmias, FDA warnsBy Saadia Aslam An FDA review of study findings showed a potential increased risk of cardiac arrhythmias in patients with pre-existing cardiac disease who are taking lamotrigine. FDA reviewed in vitro studies of lamotrigine after receiving reports of abnormal electrocardiographic…
- Underrepresentation of black participants in key Cardiology trialsBy Ahmed El-Medany In contrast to their prevalence in the overall disease population, Black individuals were considerably underrepresented in trials that affirmed the United States’ Food and Drug Administration’s (FDA) approval of 24 CVD treatments, researchers reported.A…
- ACC and AHA release key data elements and definitions for heart failureBy Ahmed El-Medany On 23 March, the American College of (ACC) and American Heart Association (AHA) released the 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure in the Journal of the American College of Cardiology.…
- Obesity increases risk of cardiovascular complications in pregnant women with heart diseaseBy Saadia Aslam Adverse CE during pregnancy were examined in a prospective cohort of women with heart disease. CE were a composite of the following: cardiac death/arrest, arrhythmias, heart failure, myocardial infarction, stroke, aortic dissection, and thromboembolic…
- Considerations for prescription of fluoroquinolones in patients developing signs or symptoms of heart valve diseaseDr Laura Dobson comments on a recent update by MHRA regarding fluoroquinolones.
The latest news, topical and relevant articles covering the entire spectrum of cardiology all in one place
